CD19 and acute lymphoblastic leukemia: Confirming the specificity of the CXCR5 CAR, the CXCR5−CD19+ B-ALL cell lines (NALM-6, REH) were not recognized by the CXCR5 CAR, but by the CD19 specific CAR-T cells.